SAS Output

13-JUL-2020 6:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1304-MM,relapsed/refractory, Car+Dex 1 N 1 Dex+Low Dose Carfilzomib 140 72 0 0 0 0 0 02/12/2014    
        2 Dex+High Dose Carfilzomib   71 0 0 0 0 0      
            143 0 0 0 0 0      
 
    2 Y 3 Dex+High Dose Carfilzomib 140 22 0 0 0 0 0 02/12/2014    
            22 0 0 0 0 0      
 
  S1803-MM, Maintenance, Len vs Len/Dara 1 Y 0 Screening 1100 158 158 102 41 18 4 08/13/2019 261 95
            158 158 102 41 18 4      
 
    2 Y 1 Lenalidomide 1100 64 64 49 24 10 2 08/13/2019    
        2 Lenalidomide + Daratumumab   59 59 44 18 5 2      
            123 123 93 42 15 4      
 
No A061202-MM, Poma/Dexa/Ixaz vs Poma/Dexa 1 E Total Registrations   2 1 1 1 0 0 07/08/2019    
            2 1 1 1 0 0      
 
  A061402-Solitary Plasmacytoma, adj sys+Zol vs Zol 0 E Total Registrations   1 0 0 0 0 0 01/27/2017    
            1 0 0 0 0 0      
 
  EAA173-MYEL, SMM, Rd +/- Daratumumab 0 E Total Registrations   13 13 12 6 4 1 01/08/2020 176 76
            13 13 12 6 4 1      
 
    1 E Total Registrations   6 6 6 1 1 0 01/08/2020    
            6 6 6 1 1 0      
 

13-JUL-2020 6:10

MMYEL Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1803 MM, Maintenance, Len vs Len/Dara 3 Second Randomization 27-Jun-19